Shilpa Medicare files patent infringement suit against Novartis over Fingolimod Medical Dialogues Team29 April 2021 5:30 AM GMTNew Delhi: In a setback to Novartis Pharmaceutical Corporation, Shilpa Pharma inc, a Shilpa Medicare subsidiary headquartered in the United States, has...
Delhi HC Restrains Eris Lifesciences from Infringing Novartis Sacubitril, Valsartan FDC Medical Dialogues Team12 April 2021 12:23 PM GMTNew Delhi: Observing that Eris Lifescience Limited has sold all the infringed products as allowed by Telangana High Court, the Delhi High Court has dis...
Novartis gets CDSCO Committee nod to Xolair to treat rhinosinusitis with nasal polyps Medical Dialogues Team17 March 2021 3:45 AM GMTNew Delhi: Subject Expert Committee (SEC) functional under Central Drugs Standard Control Organization (CDSCO) has granted permission to Novartis Healt...
Novartis India reports net loss at Rs 71 lakh in Q3 ruchika14 Feb 2021 3:30 AM GMTNew Delhi: Drug firm Novartis India on Thursday reported a net loss of Rs 71 lakh for the quarter ended December 31, 2020.The company had posted a...
Novartis gets USFDA Breakthrough Therapy designations for STAMP inhibitor asciminib to treat chronic myeloid leukemia ruchika9 Feb 2021 5:30 AM GMTAsciminib (ABL001) is an investigational treatment specifically targeting the ABL myristoyl pocket (STAMP).
Novartis to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine production ruchika1 Feb 2021 7:03 AM GMTBasel: Pharma major, Novartis, has recently announced that the company has signed an initial agreement to leverage its manufacturing capacity and ...
Covid-19: Novartis in discussion with firms for manufacturing vaccines, tests ruchika30 Jan 2021 3:30 AM GMTZurich: Novartis is talking to other companies about helping to make vaccines and tests for COVID-19, the Swiss drugmaker said on Thursday without prov...
Novartis Committed to Sandoz generic business: CEO Vas Narasimhan ruchika27 Jan 2021 7:07 AM GMTZurich: Novartis Chief Executive Vas Narasimhan on Tuesday renewed his commitment to his Sandoz generic unit where sales growth in 2020 stagnated due t...
Drugmakers agree to cut prices in half to get on China state insurance list ruchika28 Dec 2020 7:54 AM GMTNinety-six of them are branded drugs with no generic versions available in the domestic market, according to the statement.
Novartis inclisiran gets complete USFDA response letter for treating hyperlipidemia ruchika21 Dec 2020 7:31 AM GMTThe FDA stated that the agency cannot approve the NDA by the Prescription Drug User Fee Act(PDUFA) action date of December 23, 2020, due to unresolved ...
Novartis, Mesoblast ink deal worth Rs 370 crore for Remestemcel-L for Covid ARDS ruchika22 Nov 2020 5:00 AM GMTZurich: Novartis aims to boost its respiratory treatment portfolio with a $50 million deal for an off-the-shelf cell therapy from Mesoblast that it hop...
Setback: Novartis arthritis drug Canakinumab fails to help Covid patients ruchika8 Nov 2020 5:30 AM GMTZurich: Novartis's canakinumab failed to help Covid-19 patients survive without invasive ventilation compared with standard therapy, the Swiss drugmake...
